Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceIain C. Macdougall, Elena Zakharova, Yusuke Tsukamoto et al.|Kidney International|2016Cited by 474
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R. Kalra, Claes Christian Strom, John G.F. Cleland et al.|The Lancet|2022Cited by 367